Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Philadelphia PA, New York NY, Lake Success NY,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
for
Prostate Cancer (Adenocarcinoma)
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: Male
Age: 18+
Code: NCT07219303
Recruiting
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
for
Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients,
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT07167446
Early Phase 1, Recruiting
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
Location: Philadelphia PA, Cleveland OH, St Louis MO, Houston TX,
Sponsor: Solve Therapeutics
Sex: All
Age: 18+
Code: NCT07108114
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
for
Urothelial Carcinoma
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT07043972
Phase 2, Recruiting
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
for
Squamous Cell Carcinoma of Head and Neck
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT07455032
Phase 1, Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Philadelphia PA, Voorhees Township NJ, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase 2, Phase 3, Recruiting
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
for
Renal Cell Carcinoma, Urothelial Carcinoma,
Location: Philadelphia PA, Boston MA, Cleveland OH, Ann Arbor MI,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06966024
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Philadelphia PA, Rockledge PA, Basking Ridge NJ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07000084
Phase 3, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for
Leukemia, Myeloid, Acute
Location: Philadelphia PA, Newark DE, Hackensack NJ, New York NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06852222
Phase 3, Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
for
Solid Tumors
Location: Philadelphia PA, New York NY, Fairfax VA, Norfolk VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06885281
Phase 1, Phase 2, Recruiting
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer
for
Urothelial Carcinoma
Location: Philadelphia PA, Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT06356155
Phase 2, Recruiting
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndrome, Anemia
Location: Philadelphia PA, The Bronx NY, Wheeling WV,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07422480
Phase 3, Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Philadelphia PA, New York NY, Lake Success NY,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase 3, Recruiting
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
for
Breast Reconstruction Surgery
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: W.L.Gore & Associates
Sex: Female
Age: 22+
Code: NCT06556654
Recruiting
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Philadelphia PA, Fairfax VA, Boston MA, Irving TX,
Sponsor: Tagworks Pharmaceuticals BV
Sex: All
Age: 18+
Code: NCT06959706
Phase 1, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma